According to the computational methods, miR-4469 was found as a negative regulator of CDK3 by directly targeting CDK3 3′UTR, and subsequent experiments suggested that the up-regulation of miR-4469 level could be responsible for the increase of breast cancer motility. This evidence concerns the gene CDK3 and breast carcinoma.